Proactive Costs of Care (PCOC) Study

Purpose of Study

What is the Purpose of this Study?

The purpose of this study is to evaluate the Proactive Costs of Care (PCOC) educational guide and cost tracker for patients diagnosed with gynecologic cancer who are currently receiving treatment at Cedars-Sinai or one of their caregivers. Researchers want to determine whether the educational materials and session help patients and caregivers feel more confident dealing with financial concerns, improve understanding of health insurance, or reduce financial distress. These materials were developed using feedback from patients, caregivers, and health care members. Participants will be asked to engage in a 30-minute educational session with a trained educator, who will help identify top practical concerns and provide guidance through the PCOC materials that are the most relevant. The PCOC booklet and cost tracker include information on how to use insurance, dealing with employment concerns, finding personal and community support, and tracking out-of-pocket costs. Participants will also be asked to complete 2 questionnaires.


Study Eligibility

Eligibility


  • * Individuals 18 years old or older are included.
  • * Individuals diagnosed with gynecologic cancer
  • * On active systemic therapy within 30 days of enrollment
  • * Receiving treatment at Cedars-Sinai Medical Center
Show more

Study Sites

Where can I participate?



Beverly

More about this Clinical Trial

What is the full name of this clinical trial?

IIT2024-11-Liang-PCOC: An open, single-arm, single-site study to evaluate the Proactive Costs of Care intervention delivered by a trained lay educator to test feasibility with the goal of improving self-efficacy among patients with gynecologic cancer on active therapy

Study Details
Disease Type/Condition

Gynecologic Cancer

Principal Investigator
1

Liang, Margaret

Age Group

Adult

Phase

N/A

IRB Number

STUDY00003960

ClinicalTrials.gov ID

NCT07217262

Key Eligibility
ClinicalTrials.gov

How do I learn more about this study?

Email

clinicaltrials@cshs.org
Study Detail
Disease Type/Condition

Gynecologic Cancer

Principal Investigator

Liang, Margaret

Age Group

Adult

Phase

N/A

IRB Number

IIT2024-11-LIANG-PCOC

ClinicalTrials.gov ID

NCT07217262

Key Eligibility
ClinicalTrials.gov

Contact
Email
clinicaltrials@cshs.org